Alagille syndrome

Alagille syndrome (ALGS) is a multisystem genetic disorder, usually of autosomal dominant inheritance, mainly caused by pathogenic variants in the JAG1 gene and, less frequently, in NOTCH2. These alterations affect the Notch signaling pathway, which is essential during embryonic development, and cause variable abnormalities in the liver, heart, skeleton, eyes, kidneys, and vascular system.

Alagille syndrome is due in most cases to variants in JAG1, a gene that encodes a ligand of the Notch pathway; a small percentage of patients have variants in NOTCH2, which encodes a receptor of the same pathway. Notch signaling regulates communication between cells during organ formation and participates in the differentiation of intrahepatic bile ducts, cardiac structures, vertebrae, the eye, and blood vessels.

When JAG1 or NOTCH2 have pathogenic variants, this cellular communication is altered, and the development of various tissues can be incomplete or abnormal. The typical hepatic manifestation is paucity of intrahepatic bile ducts, which produces chronic cholestasis, jaundice, pruritus, xanthomas, fat malabsorption, and deficiency of fat-soluble vitamins. The disease follows an autosomal dominant pattern: a single altered copy can cause the disorder, although expressivity is highly variable, and some family members with the same variant may show mild or subclinical signs. The estimated incidence is around 1 in 30,000 to 50,000 live births.

Symptoms

The onset usually occurs in the first months of life, especially in cases with neonatal cholestasis. The main symptoms include persistent jaundice, intense pruritus, growth delay, and nutritional deficiencies. Heart disease is also common, especially peripheral pulmonary stenosis, vertebral anomalies such as butterfly vertebrae, posterior embryotoxon or other ocular abnormalities, characteristic facial features, and renal or vascular involvement. Severity is highly variable: some patients present with progressive liver disease requiring transplantation, while others have milder manifestations.

Disease management

Management is multidisciplinary and focuses on controlling cholestasis, pruritus, nutritional deficiencies, and cardiac, renal, or vascular complications. Liver treatment may include ursodeoxycholic acid, fat-soluble vitamin supplements, and nutritional support. For pruritus, medications such as rifampicin, bile acid sequestrant resins, or ileal bile acid transporter inhibitors, such as maralixibat, may be used when indicated.

Significant heart disease may require specialized intervention. In cases of liver failure or intractable pruritus, liver transplantation may be necessary, although it does not correct extrahepatic manifestations. Periodic clinical follow-up and family genetic counseling are recommended.

Genes analyzed

NOTCH2 U JAG1 U
U Ultra Whole Genome Sequencing 30x

Bibliography

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy